Harvard's Office of Technology Development and LabCentral co-host the Guppy Tank series, where Harvard life-science innovators pitch their early-stage concepts to a panel of entrepreneurs and investors for constructive, in-depth feedback.
Guppy Tank events provide industry exposure and input to research teams early in the business development process to enable them to move forward in a productive direction with their projects and position it for success. The event acts as a training tool for research teams to pitch their technology and engage in a valuable discussion with investors, entrepreneurs, and fellow scientists.
The Guppy Tank series has been running for 8 years with 30+ presentations and networking sessions.
June 9th, 2026
LabCentral, 700 Main Street Cambridge, MA 02139 Map
Harvard life-science innovators pitch their concepts to a panel of entrepreneurs and investors for constructive feedback.
May 7th, 2024
LabCentral, 700 Main Street Cambridge, MA 02139 Map
Harvard life-science innovators pitch their concepts to a panel of entrepreneurs and investors for constructive feedback.
March 7th, 2024
Northwest Building, Room B103
52 Oxford Street Cambridge, MA 02138
Harvard life-science innovators pitch their concepts to a panel of entrepreneurs and investors for constructive feedback.
November 15th, 2023
LabCentral, 700 Main Street Cambridge, MA 02139 MAP
Harvard life-science innovators pitch their concepts to a panel of entrepreneurs and investors for constructive feedback.
This event features a technology from the Church Lab presented by Dr. Erik Aznauryan, Post-Doctoral Research Fellow, Harvard Medical School, and Wyss Technology Development Fellow.
June 27th, 2023
Lab Central, 700 Main Street, North Cambridge, MA 02139 MAP
Harvard life-science innovators pitch their concepts to a panel of entrepreneurs and investors for constructive feedback.
This event features a technology from the Silver Lab presented by Jeffrey Way Ph.D., President of General Biologics. General Biologics is developing a product for treatment of hypoxia, which could be used to treat chronic obstructive pulmonary disease (16 million patients in the US alone), cystic fibrosis, and patients on ventilators.
November 30th, 2022
LabCentral, 700 Main Street North, Cambridge, MA
Harvard life-science innovators pitch their concepts to a panel of entrepreneurs and investors for constructive, in-depth feedback.